{"meta":{"query_hash":"b7b02f73b86d","filters":{"venue":"Journal of Commercial Biotechnology"},"cohort_total":20,"direct_labels_cover":0,"predictions_cover":20,"exported":20,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/b7b02f73b86d","api":"https://metacan.xera.ac/api/v1/cohort?venue=Journal+of+Commercial+Biotechnology"},"results":[{"id":"W1550526788","doi":"10.5912/jcb711","title":"The Globetrotting Regulator","year":2015,"lang":"en","type":"article","venue":"Journal of Commercial Biotechnology","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Fraternity; Government (linguistics); Battle; China; Health care; Politics; Political science; Economic growth; Public administration; Law; Economics; History; Ancient history","score_opus":0.08344887446268374,"score_gpt":0.2980808370679797,"score_spread":0.214631962605296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1550526788","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.69043875,0.011666467,0.0022827792,0.2583031,0.0037924778,0.00016137109,0.000032508957,0.000049339364,0.033273175],"genre_scores_gemma":[0.99677587,0.00054962403,0.0005246527,0.0015614061,0.0004855528,0.000001222166,2.8489018e-7,0.000011662633,0.00008970959],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99884874,0.000017849683,0.0007576199,0.0000935446,0.000028927441,0.00025331392],"domain_scores_gemma":[0.99881834,0.000084205945,0.0006884219,0.00021872857,0.00005793312,0.00013240015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013026142,0.000086450396,0.00031831174,0.00017300379,0.0001109231,0.00005290137,0.0005425364,0.00018714012,0.00002280012],"category_scores_gemma":[0.00060364394,0.00007077384,0.00012228388,0.00018182803,0.00017643564,0.00010461261,0.00010649825,0.00040727077,0.0001790763],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059957438,0.000037571255,0.0041848617,0.0000022213412,0.000061427425,0.000006000606,0.00007021026,0.00001415767,0.000078622106,0.9398313,0.025986841,0.029666806],"study_design_scores_gemma":[0.0005214255,0.00012845296,0.0013704507,0.0000034458658,0.000003979078,0.00005508604,0.000045434528,0.00021762759,0.0008538354,0.16429944,0.8324199,0.000080954705],"about_ca_topic_score_codex":0.000019185445,"about_ca_topic_score_gemma":0.0000104421815,"teacher_disagreement_score":0.806433,"about_ca_system_score_codex":0.00012575655,"about_ca_system_score_gemma":0.000056098997,"threshold_uncertainty_score":0.28860736},"labels":[],"label_agreement":null},{"id":"W1589071603","doi":"10.5912/jcb652","title":"Staking an Advantage in an AIA World: Practical Patent Tips for Biotechnology Companies","year":2014,"lang":"en","type":"article","venue":"Journal of Commercial Biotechnology","topic":"Intellectual Property and Patents","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Patentable subject matter; Investor relations; Subject matter; Bioethics; Patent law; Competitive advantage; Key (lock); Patentability; Business; Subject (documents); Biotechnology; Intellectual property; Invention; Law and economics; Law; Economics; Marketing; Strategic management; Political science; Computer science; Biology; World Wide Web; Computer security","score_opus":0.21060378146837744,"score_gpt":0.31663379071854364,"score_spread":0.1060300092501662,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1589071603","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9532226,0.000076434895,0.021809071,0.0224282,0.0011171115,0.00036149667,0.0000033671145,0.00014728196,0.00083448214],"genre_scores_gemma":[0.99373144,0.000030449286,0.003118009,0.0022278118,0.00081759,0.0000066970047,0.000011436859,0.00003446702,0.000022073224],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99823445,0.00007019679,0.0007485387,0.00026133773,0.00020250508,0.00048300019],"domain_scores_gemma":[0.9985934,0.00015132793,0.0006588466,0.00031336705,0.00025601554,0.000027064962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010842799,0.00023545342,0.00056247954,0.0016348095,0.0001921238,0.00012997205,0.0006497572,0.00050323986,0.000078466815],"category_scores_gemma":[0.00074901537,0.00019284968,0.000113370894,0.0006516313,0.00023614954,0.0011836645,0.0001933535,0.00094019977,0.000043549477],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005013874,0.0026466278,0.024363076,0.00029338588,0.0001584732,0.00018771892,0.00032811295,0.00020772837,0.039897326,0.46075356,0.0057235854,0.46042654],"study_design_scores_gemma":[0.0050821123,0.002840992,0.007089266,0.00028864728,0.00019093018,0.00026767037,0.0019181839,0.0306193,0.019350894,0.03447591,0.89685106,0.0010250438],"about_ca_topic_score_codex":0.000093412054,"about_ca_topic_score_gemma":0.0019091496,"teacher_disagreement_score":0.89112747,"about_ca_system_score_codex":0.00005914745,"about_ca_system_score_gemma":0.00003596856,"threshold_uncertainty_score":0.78641814},"labels":[],"label_agreement":null},{"id":"W1998219596","doi":"10.1057/jcb.2008.17","title":"Networks of dedicated biotechnology and service firms in Vancouver","year":2008,"lang":"en","type":"article","venue":"Journal of Commercial Biotechnology","topic":"Innovation and Knowledge Management","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Simon Fraser University","funders":"Simon Fraser University","keywords":"Embeddedness; Competitor analysis; Service (business); Business; Key (lock); Industrial organization; Marketing; Sociology; Computer science; Computer security","score_opus":0.01737890348448996,"score_gpt":0.22048751931760632,"score_spread":0.20310861583311637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998219596","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9557035,0.0005172595,0.0025450373,0.031178597,0.0013037573,0.00022259985,6.999535e-7,0.00009556865,0.008433007],"genre_scores_gemma":[0.9962703,0.00027433617,0.00036088654,0.0028098684,0.00024469802,0.0000016259769,0.0000015686376,0.000012627813,0.000024062163],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99884,0.000011640453,0.0006638172,0.00012785103,0.00013619568,0.00022050386],"domain_scores_gemma":[0.99885005,0.000026901376,0.00066457083,0.00017595425,0.00027421315,0.000008299602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003761486,0.00013466795,0.00039214263,0.0013757768,0.0000735628,0.000010619036,0.00037309967,0.0004230148,0.00003584674],"category_scores_gemma":[0.00011829784,0.00012011305,0.000045625544,0.001759422,0.0002350992,0.00021737732,0.00029306876,0.0005034785,0.000010483613],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008933831,0.0013818644,0.084051795,0.000503504,0.00031459567,0.00053996965,0.00029073202,0.00022494704,0.012292037,0.6741204,0.047226198,0.17816053],"study_design_scores_gemma":[0.010844979,0.00052386103,0.10133456,0.0004915938,0.0002194412,0.0003000672,0.0023740756,0.014187662,0.010735536,0.020395344,0.8374313,0.0011615996],"about_ca_topic_score_codex":0.00009502665,"about_ca_topic_score_gemma":0.0008348106,"teacher_disagreement_score":0.79020506,"about_ca_system_score_codex":0.000027986942,"about_ca_system_score_gemma":0.000023391935,"threshold_uncertainty_score":0.4898068},"labels":[],"label_agreement":null},{"id":"W2007032324","doi":"10.1057/palgrave.jcb.3050087","title":"Risk management for the biotechnology industry: A Canadian perspective","year":2008,"lang":"en","type":"article","venue":"Journal of Commercial Biotechnology","topic":"Biotechnology and Related Fields","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Risk management; Business; New product development; Strategic planning; Order (exchange); Position (finance); Enterprise risk management; Corporate governance; Product (mathematics); Market risk; Profit (economics); Industrial organization; Finance; Marketing; Economics","score_opus":0.0166169519568604,"score_gpt":0.27076712544454595,"score_spread":0.25415017348768554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007032324","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16401216,0.0053356485,0.0063607567,0.8194901,0.0012046933,0.0009687819,0.000026788512,0.00017114457,0.0024299286],"genre_scores_gemma":[0.97704476,0.015884886,0.0039033827,0.0026502463,0.00022754533,0.000016432363,0.0000014966206,0.000025873256,0.00024536042],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986249,0.000040731098,0.0004777157,0.0002160553,0.00015481925,0.00048576048],"domain_scores_gemma":[0.99857295,0.00013279227,0.00038660332,0.0005044544,0.0002568736,0.00014630525],"candidate_categories":["research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00039670715,0.00020551724,0.00050324557,0.0011459013,0.0005688257,0.0000058242326,0.00057739054,0.0095433565,0.000053313],"category_scores_gemma":[0.00040398972,0.00013543981,0.00026725273,0.0007521357,0.00115582,0.00004279281,0.00009502106,0.008786071,0.00001849293],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021061928,0.00069746404,0.007856566,0.0000481997,0.0054219803,0.0029801838,0.0009249086,0.000031270087,0.0025331355,0.6844706,0.09661411,0.19631541],"study_design_scores_gemma":[0.0050719427,0.0030931018,0.017482355,0.000111581845,0.0013060722,0.013791665,0.0043765362,0.00009872496,0.029038638,0.010916568,0.9143423,0.00037050009],"about_ca_topic_score_codex":0.003317173,"about_ca_topic_score_gemma":0.0032024435,"teacher_disagreement_score":0.8177282,"about_ca_system_score_codex":0.00029773894,"about_ca_system_score_gemma":0.00036855577,"threshold_uncertainty_score":0.9935007},"labels":[],"label_agreement":null},{"id":"W2014084367","doi":"10.5912/jcb645","title":"Market Orientation, Alliance Orientation, and Business Performance in the Biotechnology Industry","year":2014,"lang":"en","type":"article","venue":"Journal of Commercial Biotechnology","topic":"Innovation and Knowledge Management","field":"Business, Management and Accounting","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Alliance; Commercialization; Market orientation; Business; Mediation; Marketing; Biotechnology; Business administration; Industrial organization; Biology; Sociology","score_opus":0.01374928068249951,"score_gpt":0.24031212292133003,"score_spread":0.22656284223883053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014084367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.886477,0.000118607284,0.0018732162,0.07719129,0.0011406943,0.00025944258,5.671874e-7,0.000064098094,0.032875113],"genre_scores_gemma":[0.9943877,0.00015056819,0.00040318328,0.0044165207,0.0005494453,0.000007153993,0.0000030100152,0.000011015996,0.00007138827],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988337,0.00003347971,0.0005482405,0.00016370196,0.00020016983,0.00022072028],"domain_scores_gemma":[0.9987772,0.000049890663,0.000558853,0.00023263365,0.00037493257,0.000006477246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012665978,0.00014471156,0.00023782226,0.00070556893,0.0001640094,0.000097402386,0.00050989905,0.0004025624,0.000043367665],"category_scores_gemma":[0.0004248906,0.00010943956,0.000026984013,0.001987589,0.00023212611,0.00046739806,0.00014794835,0.00070764153,0.000022168897],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000120450015,0.0001602146,0.07668011,0.00012329889,0.000024522391,0.000013988213,0.00010849444,0.000010377611,0.00024946165,0.78561664,0.009268762,0.12762369],"study_design_scores_gemma":[0.0015633444,0.00008481553,0.2542453,0.00008867176,0.00004193335,0.00005928697,0.0013448063,0.0006956899,0.0004349753,0.008856558,0.73234814,0.00023648808],"about_ca_topic_score_codex":0.000014015811,"about_ca_topic_score_gemma":0.00006541908,"teacher_disagreement_score":0.7767601,"about_ca_system_score_codex":0.00003122918,"about_ca_system_score_gemma":0.000022246999,"threshold_uncertainty_score":0.44628158},"labels":[],"label_agreement":null},{"id":"W2025816121","doi":"10.1057/palgrave.jcb.3040051","title":"What will it take to get institutional investors interested in life sciences again?","year":2003,"lang":"en","type":"article","venue":"Journal of Commercial Biotechnology","topic":"Biotechnology and Related Fields","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Quest University Canada","funders":"","keywords":"Investor relations; Appeal; Business; Institutional investor; State (computer science); Accounting; Strategic management; Marketing; Finance; Political science; Corporate governance; Law","score_opus":0.03381963124527491,"score_gpt":0.3068567244523679,"score_spread":0.27303709320709296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025816121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.69073874,0.001598241,0.0006215776,0.30481398,0.0013844768,0.00015020046,7.8459027e-7,0.000037362548,0.00065465935],"genre_scores_gemma":[0.98119414,0.0027796743,0.0021234844,0.013753048,0.00008121185,0.0000023921955,8.578808e-7,0.000008994294,0.000056191726],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99846816,0.00009096201,0.0006696067,0.00020549349,0.00023372157,0.00033205168],"domain_scores_gemma":[0.999192,0.00007184895,0.00024043427,0.00021304337,0.00011203043,0.00017065935],"candidate_categories":["research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0007440135,0.00016664383,0.0004964576,0.0014981274,0.00013389207,0.000017606255,0.00036893078,0.0032172618,0.00008323106],"category_scores_gemma":[0.0015048482,0.000130467,0.00011225272,0.0012086162,0.0010222059,0.00030336578,0.00008233735,0.0035985906,0.000027578177],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027229125,0.003423647,0.07891191,0.00017107146,0.001038859,0.0037815727,0.0029614065,0.0009212908,0.08491111,0.6376024,0.064474426,0.11907938],"study_design_scores_gemma":[0.0057140095,0.0058229063,0.021139216,0.001787717,0.00016050179,0.0056965156,0.0042516273,0.00006226921,0.07962687,0.006553927,0.8685851,0.0005993554],"about_ca_topic_score_codex":0.0000107573305,"about_ca_topic_score_gemma":0.00010101025,"teacher_disagreement_score":0.80411065,"about_ca_system_score_codex":0.00011514736,"about_ca_system_score_gemma":0.000558675,"threshold_uncertainty_score":0.99870014},"labels":[],"label_agreement":null},{"id":"W2028247102","doi":"10.5912/jcb649","title":"Canadian Venture Capital - Unlocking the Funding Challenge","year":2014,"lang":"en","type":"article","venue":"Journal of Commercial Biotechnology","topic":"Private Equity and Venture Capital","field":"Business, Management and Accounting","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Venture capital; Social venture capital; Business; Government (linguistics); Finance; Entrepreneurship; Seed money; New Ventures","score_opus":0.016499741728111854,"score_gpt":0.21976204990614884,"score_spread":0.20326230817803698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028247102","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7962867,0.0009874773,0.00077654043,0.19066714,0.0032531023,0.00013171033,0.000001938429,0.00006792441,0.007827458],"genre_scores_gemma":[0.9935165,0.00006938828,0.000038867933,0.0031681275,0.0031711014,0.0000010466664,0.0000024844232,0.000016310893,0.00001619495],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99894494,0.000020721824,0.00033132345,0.000113241134,0.00019477394,0.00039499596],"domain_scores_gemma":[0.9991644,0.00005190475,0.0004020049,0.0002333559,0.00011702509,0.000031318126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007236599,0.00014859384,0.00025768668,0.00051912165,0.0003585213,0.00013748734,0.00083896215,0.00032035526,0.000092995],"category_scores_gemma":[0.00032396143,0.000105693725,0.00014546921,0.00031879198,0.00012244814,0.0004224305,0.00019574737,0.0008071433,0.000087819986],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005829392,0.000098292956,0.004310589,0.000057056775,0.00012387907,0.00010043832,0.00027448562,0.000027398488,0.0014151289,0.8471341,0.016637238,0.12976308],"study_design_scores_gemma":[0.0004944274,0.00008982417,0.0046387496,0.0000635433,0.0000716121,0.00007717832,0.000495473,0.00015448527,0.0002617102,0.029549314,0.9638935,0.000210222],"about_ca_topic_score_codex":0.0034522791,"about_ca_topic_score_gemma":0.023847079,"teacher_disagreement_score":0.9472562,"about_ca_system_score_codex":0.00010652841,"about_ca_system_score_gemma":0.000056775352,"threshold_uncertainty_score":0.99396515},"labels":[],"label_agreement":null},{"id":"W2053826437","doi":"10.1057/jcb.2011.26","title":"Catalyzing capital for Canada's life sciences industry","year":2011,"lang":"en","type":"article","venue":"Journal of Commercial Biotechnology","topic":"Private Equity and Venture Capital","field":"Business, Management and Accounting","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Investor relations; Bioethics; Business; Capital (architecture); Strategic management; Economics; Management; Political science; Marketing; Geography","score_opus":0.04632110799597593,"score_gpt":0.24183735550165678,"score_spread":0.19551624750568086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053826437","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9800714,0.00043512371,0.000604957,0.015055165,0.0016759135,0.00010591276,0.0000046519262,0.000032314685,0.0020145217],"genre_scores_gemma":[0.9958955,0.000014983489,0.00045402173,0.002417232,0.0011940154,0.0000017968366,0.0000017547211,0.0000096976155,0.000010974949],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99903184,0.0000054345855,0.0003679926,0.000117223266,0.00018462502,0.00029286204],"domain_scores_gemma":[0.9991765,0.000036057812,0.000495952,0.00011447547,0.00015320553,0.000023784145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043314436,0.00012065079,0.00025610937,0.00033849617,0.00023141065,0.000038820843,0.00070273207,0.00035992757,0.00007054784],"category_scores_gemma":[0.00052494125,0.00010293073,0.00009000628,0.00031605797,0.00023066107,0.000521185,0.00019549223,0.00055890373,0.000006231321],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057801616,0.00057012023,0.05928961,0.00024654146,0.00036104888,0.00024600385,0.0003679911,0.00001772896,0.00670892,0.6861825,0.1816413,0.06379025],"study_design_scores_gemma":[0.0039075487,0.00079435797,0.06447785,0.00025070753,0.000422846,0.00026348725,0.00523548,0.00021361739,0.030365847,0.06459027,0.82812244,0.0013555721],"about_ca_topic_score_codex":0.02895403,"about_ca_topic_score_gemma":0.044552986,"teacher_disagreement_score":0.6464811,"about_ca_system_score_codex":0.000047447204,"about_ca_system_score_gemma":0.00034284682,"threshold_uncertainty_score":0.97751224},"labels":[],"label_agreement":null},{"id":"W2057868875","doi":"10.1057/jcb.2008.16","title":"A comparison of R&D indicators for the Vancouver biotechnology cluster","year":2008,"lang":"en","type":"article","venue":"Journal of Commercial Biotechnology","topic":"Innovation Policy and R&D","field":"Economics, Econometrics and Finance","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Simon Fraser University","funders":"","keywords":"Investor relations; Bioethics; Cluster (spacecraft); Biotechnology; Business; Strategic management; Economics; Political science; Marketing; Biology; Computer science; Law","score_opus":0.08105818552773462,"score_gpt":0.3141772405014212,"score_spread":0.23311905497368657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057868875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7981044,0.0030078504,0.12688737,0.0671172,0.0028916274,0.0004317937,0.000100439225,0.000051129246,0.0014081883],"genre_scores_gemma":[0.9954697,0.00041966327,0.0028767423,0.0008933091,0.00017542549,0.0000059509057,0.0000014616311,0.000014602043,0.00014317408],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99831116,0.000014308203,0.0012629897,0.00012732472,0.0000473312,0.00023688814],"domain_scores_gemma":[0.99763787,0.00019613675,0.0017330282,0.000317208,0.00009031248,0.00002547367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005723748,0.00012020966,0.0006295275,0.0011339404,0.00019151438,0.0000053632475,0.000615762,0.00062605087,0.0000638103],"category_scores_gemma":[0.00043550978,0.000095418516,0.00019618814,0.0007472088,0.0005686522,0.00007921371,0.000088902816,0.00055985956,0.000022858705],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030111018,0.00044869867,0.033283565,0.000035708654,0.00033937616,0.0000027139629,0.0009566649,0.00008235563,0.0009926872,0.7779101,0.1651059,0.020541124],"study_design_scores_gemma":[0.0011333106,0.00041823232,0.005254335,0.000010239812,0.000017160823,0.000057419573,0.00013109807,0.00012421119,0.01806598,0.017216949,0.95742655,0.00014449967],"about_ca_topic_score_codex":0.00003499084,"about_ca_topic_score_gemma":0.00007833732,"teacher_disagreement_score":0.79232067,"about_ca_system_score_codex":0.00005156751,"about_ca_system_score_gemma":0.00004810635,"threshold_uncertainty_score":0.48286778},"labels":[],"label_agreement":null},{"id":"W2080277760","doi":"10.1057/jcb.2008.19","title":"Connecting product innovation management and marketing","year":2008,"lang":"en","type":"article","venue":"Journal of Commercial Biotechnology","topic":"Business Strategy and Innovation","field":"Business, Management and Accounting","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"","keywords":"Investor relations; Business; Marketing; Product (mathematics); Marketing management; Product management; Strategic management; Product strategy; New product development","score_opus":0.027292386017886923,"score_gpt":0.23310330541497049,"score_spread":0.20581091939708357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080277760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9816459,0.00015388316,0.001685387,0.0117956335,0.00048230917,0.00009847741,1.7425802e-7,0.000057911857,0.00408037],"genre_scores_gemma":[0.9965833,0.00010892441,0.001808153,0.0007650487,0.0006978278,0.0000011604504,0.000002809169,0.000011253495,0.000021539961],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99909157,0.000010763837,0.00049165846,0.0001174114,0.00013708384,0.00015153598],"domain_scores_gemma":[0.99878913,0.000023604409,0.000680869,0.00010387237,0.000399099,0.0000034023024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078829244,0.000105297055,0.00019294379,0.00094125565,0.00026136092,0.00004771066,0.00015402651,0.00011537177,0.000027383403],"category_scores_gemma":[0.00032146863,0.00009565068,0.000023970333,0.0014319721,0.00008319267,0.00072882324,0.000113159265,0.00029570019,0.000008105848],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000461764,0.00017797433,0.03674046,0.0003358324,0.00012112947,0.00016918637,0.000051092135,0.000034615703,0.013716204,0.40437675,0.0066521945,0.5371628],"study_design_scores_gemma":[0.0028537677,0.00010542207,0.5229859,0.0003341117,0.00013859392,0.0012308874,0.00079222117,0.0004923201,0.0077239624,0.013329191,0.4493541,0.0006595408],"about_ca_topic_score_codex":0.00001389223,"about_ca_topic_score_gemma":0.0000044211956,"teacher_disagreement_score":0.53650326,"about_ca_system_score_codex":0.000017498463,"about_ca_system_score_gemma":0.00001205156,"threshold_uncertainty_score":0.39005214},"labels":[],"label_agreement":null},{"id":"W2090438504","doi":"10.5912/jcb660","title":"To Market, To Market: Ontario, Canada’s vision to improve commercialization of healthcare research","year":2014,"lang":"en","type":"article","venue":"Journal of Commercial Biotechnology","topic":"Innovation Policy and R&D","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Commercialization; Government (linguistics); Investment (military); Business; Market analysis; Incentive; Seed money; Finance; Capital market; Health care; Investor relations; Bioethics; Venture capital; Marketing; Economic growth; Strategic management; Economics; Market economy; Political science","score_opus":0.04601344928933147,"score_gpt":0.325259145699664,"score_spread":0.27924569641033253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090438504","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.49728355,0.00007637378,0.023573566,0.4625173,0.0019224618,0.00083812076,0.00013723862,0.000023427086,0.013627981],"genre_scores_gemma":[0.9830173,0.000018605118,0.0036574283,0.011852687,0.0003053057,0.000011553288,0.0000024048559,0.00002550557,0.001109158],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.997667,0.00011074085,0.0012935826,0.00027743957,0.00016318205,0.0004880368],"domain_scores_gemma":[0.9980628,0.00012937255,0.00046940302,0.00046213035,0.0005812208,0.00029508484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035660332,0.00015004611,0.000636158,0.0027045477,0.00019815094,0.000036449735,0.0006898459,0.00038747647,0.00032637082],"category_scores_gemma":[0.001399371,0.00016321558,0.00008409857,0.0018313286,0.000059296748,0.00009551887,0.00027919593,0.00064216735,0.000100801895],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010876093,0.00021699083,0.014554723,0.000070905524,0.000061601466,0.0000056657955,0.001978853,0.00007393689,0.00347047,0.39669693,0.50100416,0.08077814],"study_design_scores_gemma":[0.0004136115,0.0023381496,0.07544059,0.00008246953,0.0000032127307,0.000007666973,0.00008399321,0.00004124939,0.0044080936,0.0069683306,0.9100144,0.00019821433],"about_ca_topic_score_codex":0.06690057,"about_ca_topic_score_gemma":0.14302486,"teacher_disagreement_score":0.4857338,"about_ca_system_score_codex":0.0006514711,"about_ca_system_score_gemma":0.00020645617,"threshold_uncertainty_score":0.939313},"labels":[],"label_agreement":null},{"id":"W2145272108","doi":"10.5912/jcb408","title":"Solid organ xenotransplantation: Progress, promise and regulatory issues","year":2001,"lang":"en","type":"article","venue":"Journal of Commercial Biotechnology","topic":"Xenotransplantation and immune response","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Xenotransplantation; Immunosuppression; Immune system; Immunology; Organ transplantation; Transplantation; Biology; Population; Medicine; Environmental health; Internal medicine","score_opus":0.014198992702565066,"score_gpt":0.33058382333065617,"score_spread":0.3163848306280911,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145272108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94375515,0.0039203186,0.00026769028,0.0515426,0.0001575971,0.0001778185,0.0000027657302,0.000054302578,0.00012174971],"genre_scores_gemma":[0.98870945,0.008609412,0.0017910175,0.0005078828,0.00016878467,0.0000020508012,0.000004941331,0.000017073029,0.00018937548],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989872,0.000062959596,0.00046029812,0.00010833848,0.00019882491,0.00018240967],"domain_scores_gemma":[0.99931985,0.000037744172,0.00022476097,0.00016277497,0.00015489983,0.0000999888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026738606,0.00012757574,0.00039222997,0.00032076938,0.000080468686,0.000015381094,0.00011421539,0.0002881822,0.00009623879],"category_scores_gemma":[0.00005418511,0.00010346137,0.000073466894,0.00023697251,0.00032690246,0.000110389214,0.000014129119,0.0004143448,0.000010847463],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018016063,0.0010222173,0.075843655,0.00040018593,0.0006090732,0.0035440356,0.0025231089,0.0000020198445,0.60629743,0.004643236,0.0045148726,0.2825841],"study_design_scores_gemma":[0.00842869,0.003500988,0.3908101,0.00062503974,0.0005181301,0.030471295,0.00044912935,0.000029868932,0.41850743,0.00064657826,0.14566845,0.00034431263],"about_ca_topic_score_codex":0.0000042459656,"about_ca_topic_score_gemma":0.0000055962682,"teacher_disagreement_score":0.31496644,"about_ca_system_score_codex":0.000028796083,"about_ca_system_score_gemma":0.00012489468,"threshold_uncertainty_score":0.42190322},"labels":[],"label_agreement":null},{"id":"W2515152034","doi":"10.5912/jcb749","title":"The BIEM Verification Study: Experienced Venture Capitalists Assess a Biopharmaceuticals Innovation Expertise Model","year":2016,"lang":"en","type":"article","venue":"Journal of Commercial Biotechnology","topic":"Biotechnology and Related Fields","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Venture capital; Biopharmaceutical; Investment (military); Intellectual property; Business; Order (exchange); Sample (material); Marketing; Economics; Industrial organization; Finance; Computer science; Biotechnology; Political science","score_opus":0.0560629197665981,"score_gpt":0.36381064964908283,"score_spread":0.3077477298824847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2515152034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8277861,0.0010291907,0.008035036,0.16218154,0.0005287811,0.00029111706,0.0000017791841,0.0000739638,0.000072510324],"genre_scores_gemma":[0.99654794,0.0021616358,0.0003735881,0.000691522,0.00010529817,0.000015828691,7.64361e-7,0.0000138335945,0.00008958953],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99857795,0.00007215446,0.0006848894,0.00016818337,0.00024640176,0.00025040426],"domain_scores_gemma":[0.99867254,0.000082971965,0.00043773736,0.0004049559,0.0003463744,0.00005539653],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0005179052,0.0001491074,0.00032669553,0.0004130602,0.00021954214,0.000014828803,0.0003669456,0.0022671975,0.000019165303],"category_scores_gemma":[0.000515008,0.000074806514,0.000086814056,0.00068705203,0.0005251574,0.000113072274,0.00007706341,0.0017088432,0.000010837764],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010810744,0.0006562623,0.00092541415,0.000008107829,0.0002295138,0.00011901666,0.0006911389,0.000002622642,0.7088737,0.032283895,0.0015760962,0.25355318],"study_design_scores_gemma":[0.008504821,0.0036810818,0.009719873,0.0002871275,0.0003554427,0.0016018138,0.0033122997,0.0006843286,0.9064603,0.0040418017,0.060910996,0.0004401141],"about_ca_topic_score_codex":0.000002367521,"about_ca_topic_score_gemma":0.0000035038904,"teacher_disagreement_score":0.25311306,"about_ca_system_score_codex":0.00011143945,"about_ca_system_score_gemma":0.00014243556,"threshold_uncertainty_score":0.9990281},"labels":[],"label_agreement":null},{"id":"W2897282897","doi":"10.5912/jcb831","title":"Patenting Bioinformatic Inventions: Global Perspective","year":2018,"lang":"en","type":"article","venue":"Journal of Commercial Biotechnology","topic":"Genetics, Bioinformatics, and Biomedical Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Patentability; Patentable subject matter; Subject matter; Subject (documents); European patent office; Perspective (graphical); Biotechnology; Engineering; Computer science; Business; Intellectual property; Biology; Political science; Patent law; Law; International trade; World Wide Web; Artificial intelligence","score_opus":0.02433703132021235,"score_gpt":0.32243443082119083,"score_spread":0.29809739950097847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2897282897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95478034,0.0011011098,0.02390747,0.010495314,0.0013394193,0.00025247099,0.000032576263,0.000030260808,0.008061062],"genre_scores_gemma":[0.99234277,0.0007030149,0.005528045,0.0005915101,0.0007446601,0.0000017439636,0.000008635138,0.00000877736,0.00007084874],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9985185,0.000053746026,0.0006309409,0.00012250111,0.00030904487,0.00036523928],"domain_scores_gemma":[0.9984706,0.00001324356,0.00038666767,0.00027270737,0.0007146756,0.00014213033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055765297,0.00014375403,0.00024151013,0.00019667421,0.00014672003,0.000036917936,0.00056652783,0.0004381628,0.000040247483],"category_scores_gemma":[0.00094424654,0.0001172518,0.00018252678,0.00032266608,0.00082283723,0.000012776305,0.00030123777,0.00028141827,0.0000665124],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012777264,0.0010173215,0.013177949,0.00019608093,0.0011755934,0.00005751197,0.0010115182,0.0000060076463,0.25990316,0.020886526,0.07579873,0.62549186],"study_design_scores_gemma":[0.005315852,0.01697374,0.017269747,0.0002710449,0.0001996105,0.0015759781,0.009902766,0.0006068881,0.49568182,0.021151137,0.43000638,0.0010450243],"about_ca_topic_score_codex":0.000022789201,"about_ca_topic_score_gemma":0.0000754008,"teacher_disagreement_score":0.62444687,"about_ca_system_score_codex":0.000082627084,"about_ca_system_score_gemma":0.00022536497,"threshold_uncertainty_score":0.47813895},"labels":[],"label_agreement":null},{"id":"W4230780364","doi":"10.5912/jcb235","title":"Risk management for the biotechnology industry: A Canadian perspective","year":2008,"lang":"en","type":"article","venue":"Journal of Commercial Biotechnology","topic":"Biotechnology and Related Fields","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Risk management; Business; New product development; Strategic planning; Order (exchange); Position (finance); Corporate governance; Enterprise risk management; Product (mathematics); Market risk; Profit (economics); Industrial organization; Marketing; Finance; Economics","score_opus":0.0166169519568604,"score_gpt":0.27076712544454595,"score_spread":0.25415017348768554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230780364","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16401216,0.0053356485,0.0063607567,0.8194901,0.0012046933,0.0009687819,0.000026788512,0.00017114457,0.0024299286],"genre_scores_gemma":[0.97704476,0.015884886,0.0039033827,0.0026502463,0.00022754533,0.000016432363,0.0000014966206,0.000025873256,0.00024536042],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986249,0.000040731098,0.0004777157,0.0002160553,0.00015481925,0.00048576048],"domain_scores_gemma":[0.99857295,0.00013279227,0.00038660332,0.0005044544,0.0002568736,0.00014630525],"candidate_categories":["research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00039670715,0.00020551724,0.00050324557,0.0011459013,0.0005688257,0.0000058242326,0.00057739054,0.0095433565,0.000053313],"category_scores_gemma":[0.00040398972,0.00013543981,0.00026725273,0.0007521357,0.00115582,0.00004279281,0.00009502106,0.008786071,0.00001849293],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021061928,0.00069746404,0.007856566,0.0000481997,0.0054219803,0.0029801838,0.0009249086,0.000031270087,0.0025331355,0.6844706,0.09661411,0.19631541],"study_design_scores_gemma":[0.0050719427,0.0030931018,0.017482355,0.000111581845,0.0013060722,0.013791665,0.0043765362,0.00009872496,0.029038638,0.010916568,0.9143423,0.00037050009],"about_ca_topic_score_codex":0.003317173,"about_ca_topic_score_gemma":0.0032024435,"teacher_disagreement_score":0.8177282,"about_ca_system_score_codex":0.00029773894,"about_ca_system_score_gemma":0.00036855577,"threshold_uncertainty_score":0.9935007},"labels":[],"label_agreement":null},{"id":"W4242147379","doi":"10.5912/jcb249","title":"Networks of dedicated biotechnology and service firms in Vancouver","year":2008,"lang":"en","type":"article","venue":"Journal of Commercial Biotechnology","topic":"Innovation and Knowledge Management","field":"Business, Management and Accounting","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Embeddedness; Competitor analysis; Service (business); Business; Key (lock); Industrial organization; Network structure; Economic geography; Marketing; Economics; Computer science; Sociology","score_opus":0.01737890348448996,"score_gpt":0.22048751931760632,"score_spread":0.20310861583311637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242147379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9557035,0.0005172595,0.0025450373,0.031178597,0.0013037573,0.00022259985,6.999535e-7,0.00009556865,0.008433007],"genre_scores_gemma":[0.9962703,0.00027433617,0.00036088654,0.0028098684,0.00024469802,0.0000016259769,0.0000015686376,0.000012627813,0.000024062163],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99884,0.000011640453,0.0006638172,0.00012785103,0.00013619568,0.00022050386],"domain_scores_gemma":[0.99885005,0.000026901376,0.00066457083,0.00017595425,0.00027421315,0.000008299602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003761486,0.00013466795,0.00039214263,0.0013757768,0.0000735628,0.000010619036,0.00037309967,0.0004230148,0.00003584674],"category_scores_gemma":[0.00011829784,0.00012011305,0.000045625544,0.001759422,0.0002350992,0.00021737732,0.00029306876,0.0005034785,0.000010483613],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008933831,0.0013818644,0.084051795,0.000503504,0.00031459567,0.00053996965,0.00029073202,0.00022494704,0.012292037,0.6741204,0.047226198,0.17816053],"study_design_scores_gemma":[0.010844979,0.00052386103,0.10133456,0.0004915938,0.0002194412,0.0003000672,0.0023740756,0.014187662,0.010735536,0.020395344,0.8374313,0.0011615996],"about_ca_topic_score_codex":0.00009502665,"about_ca_topic_score_gemma":0.0008348106,"teacher_disagreement_score":0.79020506,"about_ca_system_score_codex":0.000027986942,"about_ca_system_score_gemma":0.000023391935,"threshold_uncertainty_score":0.4898068},"labels":[],"label_agreement":null},{"id":"W4242946094","doi":"10.1057/palgrave.jcb.3040180","title":"Legal and regulatory update","year":2006,"lang":"en","type":"article","venue":"Journal of Commercial Biotechnology","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"ASTER","funders":"","keywords":"Investor relations; Business; Law and economics; Strategic management; Economics; Marketing","score_opus":0.007729958218176922,"score_gpt":0.2611671433256631,"score_spread":0.2534371851074862,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242946094","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8032014,0.001469824,0.0011334817,0.19312549,0.00029583622,0.00005464671,0.0000011234431,0.000024364976,0.0006938491],"genre_scores_gemma":[0.9967723,0.0002732774,0.0016698602,0.00079915585,0.00038930002,2.1051522e-7,0.0000020946584,0.000006826145,0.00008701506],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992836,0.000020077186,0.0003267712,0.00006871336,0.00018659211,0.00011422258],"domain_scores_gemma":[0.99953157,0.0000194052,0.00018489825,0.00010637891,0.00009713698,0.000060586688],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028758176,0.00006698715,0.0002438044,0.0002348239,0.000047255147,0.000007926562,0.0000634495,0.00048720147,0.00002414699],"category_scores_gemma":[0.000029237464,0.0000483817,0.000061391074,0.00014326988,0.0007565328,0.00004550437,0.000035575933,0.00054286007,0.0000029802566],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038694116,0.000264196,0.0026866181,0.00005893792,0.00008665974,0.0002671521,0.000024675634,0.0000017874308,0.11165012,0.4693421,0.016016347,0.39921445],"study_design_scores_gemma":[0.002330972,0.0008200018,0.17212638,0.00010432127,0.00013317038,0.0030299928,0.000034179397,0.000075239965,0.03303389,0.028867945,0.75931525,0.00012865986],"about_ca_topic_score_codex":0.000023779608,"about_ca_topic_score_gemma":0.000016436154,"teacher_disagreement_score":0.7432989,"about_ca_system_score_codex":0.000026037407,"about_ca_system_score_gemma":0.00008656353,"threshold_uncertainty_score":0.37577438},"labels":[],"label_agreement":null},{"id":"W4246549027","doi":"10.5912/jcb246","title":"A comparison of R&D indicators for the Vancouver biotechnology cluster","year":2008,"lang":"en","type":"article","venue":"Journal of Commercial Biotechnology","topic":"Innovation Policy and R&D","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Kingston Health Sciences Centre; Administrative Sciences Association of Canada; Simon Fraser University","funders":"Industry Canada; Government of Canada; Departamento Administrativo de Ciencia, Tecnología e Innovación (COLCIENCIAS)","keywords":"Revenue; Investor relations; Intellectual property; Biotechnology; Cluster (spacecraft); Value (mathematics); Variety (cybernetics); Business; Bioethics; Economics; Marketing; Biology; Strategic management; Political science; Accounting; Law; Computer science","score_opus":0.08105818552773462,"score_gpt":0.3141772405014212,"score_spread":0.23311905497368657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4246549027","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7981044,0.0030078504,0.12688737,0.0671172,0.0028916274,0.0004317937,0.000100439225,0.000051129246,0.0014081883],"genre_scores_gemma":[0.9954697,0.00041966327,0.0028767423,0.0008933091,0.00017542549,0.0000059509057,0.0000014616311,0.000014602043,0.00014317408],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99831116,0.000014308203,0.0012629897,0.00012732472,0.0000473312,0.00023688814],"domain_scores_gemma":[0.99763787,0.00019613675,0.0017330282,0.000317208,0.00009031248,0.00002547367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005723748,0.00012020966,0.0006295275,0.0011339404,0.00019151438,0.0000053632475,0.000615762,0.00062605087,0.0000638103],"category_scores_gemma":[0.00043550978,0.000095418516,0.00019618814,0.0007472088,0.0005686522,0.00007921371,0.000088902816,0.00055985956,0.000022858705],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030111018,0.00044869867,0.033283565,0.000035708654,0.00033937616,0.0000027139629,0.0009566649,0.00008235563,0.0009926872,0.7779101,0.1651059,0.020541124],"study_design_scores_gemma":[0.0011333106,0.00041823232,0.005254335,0.000010239812,0.000017160823,0.000057419573,0.00013109807,0.00012421119,0.01806598,0.017216949,0.95742655,0.00014449967],"about_ca_topic_score_codex":0.00003499084,"about_ca_topic_score_gemma":0.00007833732,"teacher_disagreement_score":0.79232067,"about_ca_system_score_codex":0.00005156751,"about_ca_system_score_gemma":0.00004810635,"threshold_uncertainty_score":0.48286778},"labels":[],"label_agreement":null},{"id":"W4292522193","doi":"10.5912/jcb1299","title":"Impact of information technology on accounting and finance in the digital health sector","year":2022,"lang":"en","type":"article","venue":"Journal of Commercial Biotechnology","topic":"FinTech, Crowdfunding, Digital Finance","field":"Business, Management and Accounting","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Accounting; Descriptive statistics; Finance; Business; Accounting information system; Return on equity; Return on assets; Information technology; Financial accounting; Economics; Profitability index; Computer science; Statistics","score_opus":0.011310659880379806,"score_gpt":0.24839820096948814,"score_spread":0.23708754108910834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292522193","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856899,0.00016241455,0.00017319089,0.012832662,0.00017318154,0.00016439536,0.000014065992,0.000026619875,0.00076357566],"genre_scores_gemma":[0.99894327,0.000043437278,0.00006323731,0.00085237785,0.000077501536,0.000005318721,0.000004095429,0.000008384554,0.0000023882274],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99879515,0.000011494174,0.0006108025,0.00009177307,0.00023989628,0.00025088884],"domain_scores_gemma":[0.99842435,0.00006278884,0.0012592388,0.00017117299,0.00007885594,0.0000036142737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005983342,0.00013090504,0.00032789356,0.0015346424,0.0001615635,0.00010947148,0.00058879046,0.00011754931,0.00001023823],"category_scores_gemma":[0.0003863554,0.000100532125,0.00008722004,0.0015316949,0.00015712221,0.0011643986,0.0003268458,0.00079406775,0.0000055603746],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051824946,0.00045642056,0.14566648,0.00011247259,0.00004763145,0.000035463047,0.00029027023,0.00053461926,0.00037319594,0.20430952,0.0071991975,0.6404565],"study_design_scores_gemma":[0.004191583,0.004292573,0.5541762,0.00040158394,0.00003268215,0.00081874756,0.0032987269,0.0012012449,0.00049447495,0.0604151,0.3699186,0.0007584757],"about_ca_topic_score_codex":0.00009865096,"about_ca_topic_score_gemma":0.0000215915,"teacher_disagreement_score":0.63969797,"about_ca_system_score_codex":0.00013652162,"about_ca_system_score_gemma":0.00007787917,"threshold_uncertainty_score":0.4099581},"labels":[],"label_agreement":null},{"id":"W4294315141","doi":"10.5912/jcb1063","title":"Offline Digital Education for Post Registration Health Professions;systematic review by the Digital Health Education Collaboration","year":2022,"lang":"en","type":"article","venue":"Journal of Commercial Biotechnology","topic":"Foreign Language Teaching Methods","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Massive open online course; Embodied cognition; Reading (process); Observational study; Online and offline; Medical education; Psychology; Value (mathematics); Digital health; Higher education; Computer science; Outcome (game theory); Mathematics education; Knowledge management; Medicine; Health care; Artificial intelligence; Political science","score_opus":0.02259135419439102,"score_gpt":0.40764695016737984,"score_spread":0.38505559597298883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294315141","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0045112153,0.054761175,0.011683931,0.9192874,0.002568198,0.005361966,0.00024033531,0.000104491795,0.0014812818],"genre_scores_gemma":[0.9700461,0.0028848841,0.003980495,0.019408833,0.0007362785,0.00039467157,0.0005147307,0.000040809748,0.0019931984],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99670786,0.0013369609,0.0010619803,0.00014469333,0.0005029376,0.00024556066],"domain_scores_gemma":[0.99639785,0.00035476274,0.0024361198,0.0002864258,0.00042834118,0.000096510026],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.005500491,0.000118529395,0.00049535045,0.00020294098,0.00150973,0.00014343545,0.0005944647,0.00010617849,0.000019520468],"category_scores_gemma":[0.0053722872,0.00009088505,0.000120560326,0.00075443264,0.00016674832,0.000439849,0.00006191612,0.0005550405,0.000001820408],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011097882,0.0013086578,0.000057855734,0.010320152,0.000065087144,5.027942e-7,0.013150853,0.000003041257,0.00012688008,0.11754769,0.40990698,0.44740131],"study_design_scores_gemma":[0.00086342753,0.003884991,0.000074238626,0.013801222,0.00017477134,0.00027715173,0.2360968,0.000023782759,0.00008102321,0.01809896,0.7261225,0.00050114805],"about_ca_topic_score_codex":0.00023842556,"about_ca_topic_score_gemma":0.0002206958,"teacher_disagreement_score":0.96553487,"about_ca_system_score_codex":0.00092071976,"about_ca_system_score_gemma":0.0069148634,"threshold_uncertainty_score":0.9997902},"labels":[],"label_agreement":null}]}